LYRA
Lyra Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.20
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-71.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jan 8, 2026 | Cavalier Jason · officer: Chief Financial Officer | Sale | 769 | $3.36 |
| Jan 8, 2026 | Palasis Maria · director, officer: President & CEO | Sale | 1,702 | $3.36 |
| Nov 13, 2025 | PERCEPTIVE ADVISORS LLC · 10 percent owner | Sale | 4,783 | $4.31 |
| Nov 13, 2025 | PERCEPTIVE ADVISORS LLC · 10 percent owner | Sale | 7,862 | $4.06 |
| Nov 13, 2025 | PERCEPTIVE ADVISORS LLC · 10 percent owner | Sale | 28,597 | $3.90 |
| Nov 13, 2025 | PERCEPTIVE ADVISORS LLC · 10 percent owner | Sale | 537 | $4.31 |
| Nov 13, 2025 | PERCEPTIVE ADVISORS LLC · 10 percent owner | Sale | 883 | $4.06 |
| Nov 13, 2025 | PERCEPTIVE ADVISORS LLC · 10 percent owner | Sale | 3,213 | $3.90 |
| Nov 10, 2025 | PERCEPTIVE ADVISORS LLC · 10 percent owner | Sale | 28,902 | $5.18 |
| Nov 10, 2025 | PERCEPTIVE ADVISORS LLC · 10 percent owner | Sale | 17,746 | $4.75 |
| Nov 10, 2025 | PERCEPTIVE ADVISORS LLC · 10 percent owner | Sale | 16,633 | $4.54 |
| Nov 10, 2025 | PERCEPTIVE ADVISORS LLC · 10 percent owner | Sale | 3,247 | $5.18 |
| Nov 10, 2025 | PERCEPTIVE ADVISORS LLC · 10 percent owner | Sale | 1,993 | $4.75 |
| Nov 10, 2025 | PERCEPTIVE ADVISORS LLC · 10 percent owner | Sale | 1,869 | $4.54 |
| Oct 3, 2025 | Palasis Maria · director, officer: President & CEO | A-Award | 3,667 | $304 |
| Jul 14, 2025 | Palasis Maria · director, officer: President & CEO | Sale | 1,565 | $8.91 |
| Jul 14, 2025 | Cavalier Jason · officer: Chief Financial Officer | Sale | 684 | $8.91 |
| May 16, 2025 | MERRIFIELD C ANN · director | A-Award | 32,000 | $0.00 |
| May 16, 2025 | TOBIN JAMES R · director | A-Award | 32,000 | $0.00 |
| May 16, 2025 | snyderman nancy lynn MD · director | A-Award | 32,000 | $0.00 |
| May 16, 2025 | Smith W Bradford · director | A-Award | 32,000 | $0.00 |
| Jan 10, 2025 | Palasis Maria · director, officer: President & CEO | A-Award | 800,000 | $0.00 |
| Jan 10, 2025 | Cavalier Jason · officer: Chief Financial Officer | A-Award | 420,000 | $0.00 |
| Dec 11, 2024 | Palasis Maria · director, officer: President & CEO | A-Award | 183,333 | $6.07 |
| Dec 11, 2024 | Waksal Harlan · director, officer: Executive Chair | A-Award | 128,333 | $0.00 |
| Oct 18, 2024 | Palasis Maria · director, officer: President & CEO | A-Award | 300,000 | $0.00 |
| Oct 18, 2024 | Cavalier Jason · officer: Chief Financial Officer | A-Award | 100,000 | $0.00 |
| Jun 14, 2024 | ALTMAN MICHAEL SETH · director | A-Award | 30,000 | $0.31 |
| Jun 14, 2024 | Poukalov Konstantin · director | A-Award | 30,000 | $0.31 |
| Jun 14, 2024 | TOBIN JAMES R · director | A-Award | 30,000 | $0.31 |
Institutional positioning
13F filings over the trailing two quarters
New 0Increased 0Reduced 0Sold out 1
| Filer | Action | Shares | Filed |
|---|---|---|---|
| MORGAN STANLEY | Sold Out | 0 | May 27, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jan 8, 2026